We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Part D Price Controls, Patent Cliff Could Cost Industry 200 Products
Part D Price Controls, Patent Cliff Could Cost Industry 200 Products
April 20, 2012
BOSTON — Drugmakers need to lobby against price controls in Medicare Part D that have an estimated price tag upward of $100 billion, amounting to a tax on the industry, incoming PhRMA Chair John Lechleiter says.